MedTrace Logo

Applications Site Reactions After Injection of Insulin Detemir and Saline in Subjects With Diabetes

NCT00607737 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2012-09-03

No results posted yet for this study

Summary

To compare application site reactions after superficial and deep subcutaneous and intradermal injections of insulin detemir and saline in patients with diabetes

\- The patient serves as his own control, n=100 patients with diabetes

Conditions

Interventions

DRUG

insulin detemir

3 cutaneous injections

DRUG

saline

3 cutaneous injections

Sponsors & Collaborators

Principal Investigators

  • LIse Tarnow, md · Steno Diabetes Center Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-06-30
Completion
2010-07-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00607737 on ClinicalTrials.gov